Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians Different from Caucasians?
Author : Doreen Tan Su-Yin
European Cardiology Review 2018;13(2):112–4.
Overview:Ischaemic heart diseases (IHD) – mainly MI – represent a large disease burden all over the world. Almost 18 million people die each year from cardiovascular diseases,... more
Author : Sophie Mavrogeni, George Markousis-Mavrogenis, Genovefa Kolovou
European Cardiology Review 2018;13(2):95–7.
Overview:Rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, systemic vasculitides, inflammatory myopathies, systemic sclerosis and mixed connective tissue... more
Author : Giacinta Guarini, Alda Huqi, Doralisa Morrone, Paola Francesca Giuseppina Capozza, Mario Marzilli
European Cardiology Review 2018;13(2):104–11.
Overview:Although cardiovascular mortality has declined progressively in developed countries, ischaemic heart disease (IHD) and chronic stable angina cause a worse prognosis and poor... more
Author : Abdalla Ibrahim, Mohamed Ali, Thomas J Kiernan, Austin G Stack
European Cardiology Review 2018;13(2):98–103.
Overview:Erectile dysfunction (ED) is generally defined as the persistent (at least 6 months) inability to achieve and maintain penile erection sufficient to allow satisfactory sexual... more
Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS study
Author : Josep Gradolí, Verónica Vidal, Adrian JB Brady, Lorenzo Facila
European Cardiology Review 2018;13(2):115–8.
Overview:Atherosclerotic cardiovascular disease (CVD) comprises a large number of related pathologies, including ischaemic heart disease and peripheral arterial disease (PAD).... more
Effect of Percutaneous Coronary Intervention on Heart Rate Variability in Coronary Artery Disease Patients
Author : Mahmoud H Abdelnaby
European Cardiology Review 2018;13(1):60–1.
Overview:Coronary artery disease (CAD) is the most common cause of morbidity and premature mortality globally,1 and cardiac autonomic... more
Author : Dae-Hyun Lee, Jose M de la Torre Hernandez
European Cardiology Review 2018;13(1):54–9.
Overview:When Andreas Grüntzig introduced balloon coronary angioplasty in 1977 it represented the first alternative to coronary artery bypass graft surgery. However, balloon dilatation... more
Assessing the Haemodynamic Impact of Coronary Artery Stenoses: Intracoronary Flow Versus Pressure Measurements
Author : Valérie E Stegehuis, Gilbert WM Wijntjens, Tadashi Murai, Jan J Piek, Tim P van de Hoef
European Cardiology Review 2018;13(1):46–53.
Overview:The emphasis in ischaemic heart disease (IHD) diagnosis has historically been directed towards the identification of epicardial coronary stenosis by selective coronary... more
Role of Anti-inflammatory Interventions in Coronary Artery Disease: Understanding the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Author : Alberto Lorenzatti, Maria Luz Servato
European Cardiology Review 2018;13(1):38–41.
Overview:Coronary artery disease (CAD) is the leading cause of death in most countries. Compelling evidence from epidemiological, genetic and clinical studies as well as experiments in... more
Author : Ricardo A Perez de la Hoz, Sandra Patricia Swieszkowski, Federico Matias Cintora, Jose Martin Aladio, Claudia Mariana Papini, Maia Matsudo, Alejandra Silvia Scazziota
European Cardiology Review 2018;13(1):29–34.
Overview:The aim of reviewing the neuroendocrine–humoral response in acute coronary syndrome (ACS) is based on the fact that beyond the distinctive thrombotic event that defines acute... more